Medicine
Famotidine 20 mg tablet
Famotidine 20 mg tablet is a generic prescription medicine for oral use, made by 42 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 25°C (77°F), excursions permitted to 15° to 30°C (59° to 86°F).
Key facts
- Active ingredient (INN)
- Famotidine
- Brand
- Sold under the generic name
- Strength
- 20 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 30 tablets, 500 tablets and 311 more
- Manufacturers
- Alembic PharmaceuticalsIndiaZydus LifesciencesIndiaAurobindo PharmaIndiaNovadoz PharmaceuticalsIndiaAscend LaboratoriesIndiaDr. Reddy's LaboratoriesIndiaCamber PharmaceuticalsIndiaLifestar PharmaIndia42 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 25°C (77°F), excursions permitted to 15° to 30°C (59° to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A02BA03 Famotidine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 16 April 2001
- Identifiers
- RxCUI 310273, 284245DailyMed set ID 46c6d243-eefc-40ca-8bd4-4c89456f635f, fa18ed52-f038-02dd-e053-6394a90ac946, dfdca61d-8824-6230-e053-2995a90a209d +37NDC 71610-470, 80425-0329, 50268-299 +37Application ANDA075805, ANDA215767, ANDA075718 +11
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 42 labelers. The register lists 314 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 carton | 46708-293-10 | Alembic PharmaceuticalsIndia | 29 January 2016 |
| 30 tablet in 1 bottle | 46708-293-30 | Alembic PharmaceuticalsIndia | 29 January 2016 |
| 100 tablet in 1 bottle | 46708-293-31 | Alembic PharmaceuticalsIndia | 29 January 2016 |
| 500 tablet in 1 bottle | 46708-293-71 | Alembic PharmaceuticalsIndia | 29 January 2016 |
| 1000 tablet in 1 bottle | 46708-293-91 | Alembic PharmaceuticalsIndia | 29 January 2016 |
| 100 tablet in 1 carton | 62332-001-10 | Alembic PharmaceuticalsIndia | 29 January 2016 |
| 30 tablet in 1 bottle | 62332-001-30 | Alembic PharmaceuticalsIndia | 29 January 2016 |
| 100 tablet in 1 bottle | 62332-001-31 | Alembic PharmaceuticalsIndia | 29 January 2016 |
| 500 tablet in 1 bottle | 62332-001-71 | Alembic PharmaceuticalsIndia | 29 January 2016 |
| 1000 tablet in 1 bottle | 62332-001-91 | Alembic PharmaceuticalsIndia | 29 January 2016 |
| 1000 tablet, film coated in 1 bottle | 70710-1683-0 | Zydus LifesciencesIndia | 6 June 2022 |
| 100 tablet, film coated in 1 bottle | 70710-1683-1 | Zydus LifesciencesIndia | 6 June 2022 |
| 30 tablet, film coated in 1 bottle | 70710-1683-3 | Zydus LifesciencesIndia | 6 June 2022 |
| 10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 70710-1683-4 | Zydus LifesciencesIndia | 6 June 2022 |
| 500 tablet, film coated in 1 bottle | 70710-1683-5 | Zydus LifesciencesIndia | 6 June 2022 |
| 1000 tablet, film coated in 1 bottle | 70771-1702-0 | Zydus LifesciencesIndia | 6 June 2022 |
| 100 tablet, film coated in 1 bottle | 70771-1702-1 | Zydus LifesciencesIndia | 6 June 2022 |
| 30 tablet, film coated in 1 bottle | 70771-1702-3 | Zydus LifesciencesIndia | 6 June 2022 |
| 10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 70771-1702-4 | Zydus LifesciencesIndia | 6 June 2022 |
| 500 tablet, film coated in 1 bottle | 70771-1702-5 | Zydus LifesciencesIndia | 6 June 2022 |
| 100 tablet, film coated in 1 bottle | 67877-842-01 | Ascend LaboratoriesIndia | 8 July 2022 |
| 500 tablet, film coated in 1 bottle | 67877-842-05 | Ascend LaboratoriesIndia | 3 February 2025 |
| 1000 tablet, film coated in 1 bottle | 67877-842-10 | Ascend LaboratoriesIndia | 8 July 2022 |
| 100 tablet, film coated in 1 bottle | 65862-859-01 | Aurobindo PharmaIndia | 22 December 2015 |
| 500 tablet, film coated in 1 bottle | 65862-859-05 | Aurobindo PharmaIndia | 22 December 2015 |
| 30 tablet, film coated in 1 bottle | 65862-859-30 | Aurobindo PharmaIndia | 22 December 2015 |
| 10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 65862-859-78 | Aurobindo PharmaIndia | 22 December 2015 |
| 1000 tablet, film coated in 1 bottle | 65862-859-99 | Aurobindo PharmaIndia | 22 December 2015 |
| 100 tablet, film coated in 1 bottle | 31722-017-01 | Camber PharmaceuticalsIndia | 4 November 2021 |
| 1000 tablet, film coated in 1 bottle | 31722-017-10 | Camber PharmaceuticalsIndia | 4 November 2021 |
| 100 tablet, film coated in 1 bottle | 55111-119-01 | Dr. Reddy's LaboratoriesIndia | 16 April 2001 |
| 1000 tablet, film coated in 1 bottle | 55111-119-10 | Dr. Reddy's LaboratoriesIndia | 16 April 2001 |
| 30 tablet, film coated in 1 bottle | 55111-119-30 | Dr. Reddy's LaboratoriesIndia | 16 April 2001 |
| 100 tablet in 1 bottle | 70756-051-11 | Lifestar PharmaIndia | 19 October 2023 |
| 1000 tablet in 1 bottle | 70756-051-12 | Lifestar PharmaIndia | 19 October 2023 |
| 500 tablet, film coated in 1 bottle | 72205-145-05 | Novadoz PharmaceuticalsIndia | 18 September 2024 |
| 30 tablet, film coated in 1 bottle | 72205-145-30 | Novadoz PharmaceuticalsIndia | 18 September 2024 |
| 50 tablet, film coated in 1 bottle | 72205-145-50 | Novadoz PharmaceuticalsIndia | 12 November 2025 |
| 100 tablet, film coated in 1 bottle | 72205-145-91 | Novadoz PharmaceuticalsIndia | 18 September 2024 |
| 75 tablet, film coated in 1 bottle | 72205-145-98 | Novadoz PharmaceuticalsIndia | 12 November 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 15 October 1986 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Famotidine 20 mg tablet.
Other strengths and forms of Famotidine
Clinical summary
Famotidine is a histamine-2 receptor antagonist indicated in hospitalized adults, or as an alternative to oral famotidine in adults, for the treatment of active duodenal ulcer (DU), among other approved uses. MedsAcross supplies Famotidine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about FamotidineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Famotidine prescribing information (Sagent Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Famotidine 20 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.